2023-01-24 14:00:00

Hydreight Technologies Inc Begins Trading on the Frankfurt Stock Exchange

Logo GlobeNewswire

VANCOUVER, British Columbia and LAS VEGAS, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) a fast-growing telehealth platform and medical network, is pleased to announce that its common shares are now trading on the Frankfurt Stock Exchange ("FSE") and are under the symbol "SO6".

The Frankfurt Stock Exchange (FSE) is one of the world's largest international trading centers for securities. Operated by the Deutsche Boerse AG, FSE, is the largest of Germany's seven stock exchanges, and is responsible for approximately 90 percent of all securities traded in Germany. The FSE facilitates advanced electronic trading, settlement and information systems and enables cross-border trading for international investors.

Shane Madden, CEO, commented, "As a company we are excited to be listed on the Frankfurt Exchange which is a big step in accelerating the growth of Hydreight by allowing retail and institutional European investors to be part of our public equity shares."

The Company's common shares continue to be listed on the Toronto Stock Exchange Venture (TSXV) under the symbol "NURS".

To view the Companys consolidated condensed interim financial statements for the three and nine months ended September 30, 2022 please click here.


Hydreight Technologies Inc. (TSXV: NURS) is a telehealth platform and medical network that bridges the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals to deliver services independently, on their own terms, or add mobile services to existing location-based operations. The network offers medical director oversight, liability insurance, HIPAA-compliant documentation, competitively priced prescriptions via a 503B licensed pharmacy, and more. The platform includes a built-in, easy-to-use suite of fully-integrated tools for accounting, documentation, sales, inventory, booking, managing patient data, and more, making it possible to deliver fully-compliant mobile medicine across 50 states. Learn more atHydreight.com.

Patients can download Hydreight from the Apple App store or Google Play Store, and prospective service providers can sign up at:Hydreight.com/start-a-business/.

On behalf of the Board of Directors

Shane Madden
Director and Chief Executive Officer
Hydreight Technologies Inc.
Telephone: (480) 790 6886

For further information about Hydreight, please contact:

Investor Relations
Contact Abbey Vogt
Email: ir@hydreight.com
Telephone: (480) 790 6886

Marketing and Media Contact- Jessica Friedman
Email: jess@hydreight.com
Telephone: (480) 790 6886

Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements.

Use of Non-GAAP Financial Measures:
This release contains references to non-GAAP financial measures Adjusted Revenue and Adjusted Profit. The Company defines Total Revenue or Adjusted Revenue as total GAAP Revenues plus business partner commission and affiliate payouts plus the cumulative non-cash adjustments for the recognition and deferral of unearned business partner contract revenue at the opening and closing balance sheet date. The Company defines Adjusted Profit as Net income (loss) under IFRS plus the cumulative non-cash adjustments for the recognition and deferral of unearned business partner contract revenue at the opening and closing balance sheet date. There is no comparable GAAP financial measure presented in IV Hydreight Inc. and Hydreight Technologies Inc condensed consolidated interim financial statements and thus no applicable quantitative reconciliation for such non-GAAP financial measures. The Company believes that the measures provide information useful to its shareholders in understanding the Companys performance, and may assist in the evaluation of the Companys business relative to that of its peers. This data is furnished to provide additional information and does not have any standardized meaning prescribed by GAAP. Accordingly, it should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP, and is not necessarily indicative of other metrics presented in accordance with GAAP.

Cautionary Note Regarding Forward-Looking Information
This press release contains statements which constitute forward-looking information within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words may, would, could, should, will, intend, plan, anticipate, believe, estimate, expect or similar expressions and includes information regarding: expectations regarding the number of new business partners of Hydreight by the end of 2022.
Investors are cautioned that forward-looking information is not based on historical facts but instead reflect the Companys managements expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to obtain requisite regulatory and other approvals with respect to the business operated by the Company and/or the potential impact of the listing of the Companys shares on the TSXV on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time as a result of being a publicly listed entity. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Continue read on globenewswire.com

Logo GlobeNewswire
SciencePress Release2023-01-24 06:00:00
Exclusive licensing and distribution agreement signed with Salus Pharmaceuticals in Lithuania, Estonia, Latvia, Croatia, Slovenia, Serbia, North Macedonia,...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 12:15:00
Henry Schein, Inc. HSIC, the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will...

Logo GlobeNewswire
NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- TheNasdaqStock Market announced today that it will delist the common stock of Schmitt Industries, Inc. Schmitt...

Logo Nasdaq
Business / FinanceBy Mt Newswires2023-01-23 14:14:26
Financial stocks were gaining pre-bell Monday with the Financial Select Sector SPDR Fund ( XLF ) recently advancing by 0.08%. The Direxion Daily Financial...

Logo Nasdaq
TechnologyBy Zacks2023-01-23 14:45:00
For Immediate Release Chicago, IL January 23, 2023 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-23 17:25:00
Helbiz Strengthens Measures to Safeguard Shareholder Interests through ShareIntel's Investigation and Due Diligence Services for Illegal Short Selling Helbiz...

Logo GlobeNewswire
SciencePress Release2023-01-24 11:00:00
VANCOUVER, British Columbia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0), an autologous stem cell therapy company,...

Logo PR Newswire
NEW YORK, Jan. 23, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HLBZ, GE, ALLR, BBBY, and LCID. To see how...

Logo PR Newswire
NEW YORK, Jan. 23, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CRM, W, TSLA, WDC, and AMD.

Logo PR Newswire
VANCOUVER, BC, Jan. 23, 2023 /CNW/ - Trading resumes in: Company: Bioasis Technologies Inc. TSX-Venture Symbol: BTI All Issues: Yes Resumption (ET): 10:00 AM...

Logo EIN Presswire
The Hemostats Market will be predicted to grow by 2028 with share, size, growth, and global demand and is expected to grow at an industry CAGR 6.3%. NEW...

Logo Nasdaq
Business / FinanceBy Mt Newswires2023-01-23 14:13:11
Health care stocks were steady premarket Monday, with the Health Care Select Sector SPDR Fund ( XLV ) and the iShares Biotechnology ETF (IBB) unchanged....

Logo GlobeNewswire
TechnologyPress Release2023-01-24 08:37:00
CAMBRIDGE, United Kingdom, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Bango (AIM: BGO), theglobal platform for data-driven commerce, provides an update on trading for...

Logo PR Newswire
TORONTO, Jan. 24, 2023 /CNW/ - FRNT Financial Inc. (TSXV: FRNT) (OTCQB: FRFLF) (FSE: XZ3) ("FRNT" or the "Company"); an institutional capital markets and...

Logo PR Newswire
VANCOUVER, BC, Jan. 23, 2023 /CNW/ - Trading resumes in: Company: Yorkton Equity Group Inc. TSX-Venture Symbol: YEG All Issues: No Resumption (ET): 3:15 PM...

Logo PR Newswire
TORONTO, Jan. 23, 2023 /CNW/ - Inscape Corporation ("Inscape" or the "Company") (TSX: INQ) announces that following a delisting review by the Toronto Stock...

Logo PR Newswire
VANCOUVER, BC, Jan. 23, 2023 /PRNewswire/ - Uranium Royalty Corp. (NASDAQ: UROY) (TSX-V: URC) ("URC" or the "Company") invites investors and shareholders to...

Logo Nasdaq
Business / FinanceBy Fintel2023-01-23 17:36:10
Fintel reports that Jpmorgan Chase & Co has filed a 13G/A form with the SEC disclosing ownership of 6,753,629 shares of Heron Therapeutics Inc ( HRTX )....

Logo PR Newswire
TORONTO, Jan. 24, 2023 /CNW/ - Lysander Funds Limited ("Lysander") announces the January, February, and March 2023 cash distributions for each of...

Logo PR Newswire
VANCOUVER, BC, Jan. 23, 2023 /CNW/ - The following issues have been halted by IIROC: Company: Yorkton Equity Group Inc. TSX-Venture Symbol: YEG All Issues:...